Iridex: Q4 Earnings Insights
$IRIX
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Iridex (NASDAQ:IRIX) reported its Q4 earnings results on Tuesday, March 26, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Iridex missed estimated earnings by -260.0%, reporting an EPS of $-0.18 versus an estimate of $-0.05.
Revenue was down $2.74 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 7.000000000000001% increase in the share price the next day.
Here's a look at Iridex's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.12 | -0.11 | -0.12 | -0.11 |
| EPS Actual | -0.11 | -0.17 | -0.13 | -0.07 |
| Revenue Estimate | 13.48M | 14.23M | 13.64M | 15.16M |
| Revenue Actual | 12.85M | 12.86M | 13.71M | 15.20M |
To track all earnings releases for Iridex visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.